75 related articles for article (PubMed ID: 11364476)
1. PCR could help screen patients for CMV treatment.
AIDS Alert; 1997 Aug; 12(8):94-5. PubMed ID: 11364476
[TBL] [Abstract][Full Text] [Related]
2. Protease inhibitors linked to drop in CMV retinitis.
AIDS Alert; 1997 Aug; 12(8):92-4. PubMed ID: 11364475
[TBL] [Abstract][Full Text] [Related]
3. On the edge: measuring CMV viral load.
McGuire S
Posit Aware; 1997; 8(1):16-7. PubMed ID: 11364091
[TBL] [Abstract][Full Text] [Related]
4. Cytomegalovirus glycoprotein B groups in human immunodeficiency virus-infected patients with incident retinitis.
Drew WL; Chou S; Miner RC; Mohr BA; Busch MP; van der Horst CM; Asmuth DM; Kalish LA
J Infect Dis; 2002 Jul; 186(1):114-7. PubMed ID: 12089671
[TBL] [Abstract][Full Text] [Related]
5. Cytomegalovirus retinitis after immune reconstitution.
Crum NF; Blade KA
AIDS Read; 2005 Apr; 15(4):186-8. PubMed ID: 15844238
[TBL] [Abstract][Full Text] [Related]
6. Detection of opportunistic DNA viral infections by multiplex PCR among HIV infected individuals receiving care at a tertiary care hospital in South India.
Sachithanandham J; Ramamurthy M; Kannangai R; Daniel HD; Abraham OC; Rupali P; Pulimood SA; Abraham AM; Sridharan G
Indian J Med Microbiol; 2009; 27(3):210-6. PubMed ID: 19584500
[TBL] [Abstract][Full Text] [Related]
7. Characteristics of untreated AIDS-related cytomegalovirus retinitis. II. Findings in the era of highly active antiretroviral therapy (1997 to 2000).
Holland GN; Vaudaux JD; Shiramizu KM; Yu F; Goldenberg DT; Gupta A; Carlson M; Read RW; Novack RD; Kuppermann BD;
Am J Ophthalmol; 2008 Jan; 145(1):12-22. PubMed ID: 18154751
[TBL] [Abstract][Full Text] [Related]
8. Clinical risk factors for cytomegalovirus retinitis in patients with AIDS.
Hodge WG; Boivin JF; Shapiro SH; Lalonde RG; Shah KC; Murphy BD; Dionne MA; Goela A
Ophthalmology; 2004 Jul; 111(7):1326-33. PubMed ID: 15234132
[TBL] [Abstract][Full Text] [Related]
9. The prognosis of CMV retinitis among patients with AIDS in Serbia.
Dujić M; Jevtović Dj; Salemović D; Ranin J; Brmbolić B; Djurković-Djaković O
Biomed Pharmacother; 2008 Sep; 62(7):443-7. PubMed ID: 18243635
[TBL] [Abstract][Full Text] [Related]
10. Dynamics of cytomegalovirus (CMV)-specific T cells in HIV-1-infected individuals progressing to AIDS with CMV end-organ disease.
Bronke C; Palmer NM; Jansen CA; Westerlaken GH; Polstra AM; Reiss P; Bakker M; Miedema F; Tesselaar K; van Baarle D
J Infect Dis; 2005 Mar; 191(6):873-80. PubMed ID: 15717261
[TBL] [Abstract][Full Text] [Related]
11. CMV after HAART.
Posit Aware; 1998; 9(5):18, 23. PubMed ID: 11365888
[TBL] [Abstract][Full Text] [Related]
12. Discontinuation of secondary prophylaxis in patients with cytomegalovirus retinitis who have responded to highly active antiretroviral therapy.
Berenguer J; González J; Pulido F; Padilla B; Casado JL; Rubio R; Arribas JR;
Clin Infect Dis; 2002 Feb; 34(3):394-7. PubMed ID: 11753827
[TBL] [Abstract][Full Text] [Related]
13. CMV information: print, online, phone, video.
AIDS Treat News; 1996 Oct; (No 256):6-7. PubMed ID: 11363884
[TBL] [Abstract][Full Text] [Related]
14. Incidence of cytomegalovirus (CMV) retinitis in second eyes of patients with the acquired immune deficiency syndrome and unilateral CMV retinitis.
Kempen JH; Jabs DA; Wilson LA; Dunn JP; West SK
Am J Ophthalmol; 2005 Jun; 139(6):1028-34. PubMed ID: 15953432
[TBL] [Abstract][Full Text] [Related]
15. Cytomegalovirus (CMV) polymerase chain reaction profiles in individuals with advanced human immunodeficiency virus infection: relationship to CMV disease.
Nokta MA; Holland F; De Gruttola V; Emery VC; Jacobson MA; Griffiths P; Pollard RB; Feinberg JE;
J Infect Dis; 2002 Jun; 185(12):1717-22. PubMed ID: 12085316
[TBL] [Abstract][Full Text] [Related]
16. Association of cytomegalovirus (CMV)-specific CD4+ T lymphocyte reactivity and protective immunity against acquired immunodeficiency syndrome-related CMV retinitis.
Jacobson MA; Bredt BM
J Infect Dis; 2002 Dec; 186(11):1701-2; author reply 1702-3. PubMed ID: 12447752
[No Abstract] [Full Text] [Related]
17. Stopping CMV prophylaxis with HAART.
TreatmentUpdate; 1998 Sep; 10(7):4-6. PubMed ID: 11365782
[TBL] [Abstract][Full Text] [Related]
18. Cytomegalovirus retinitis in the era of highly active antiretroviral therapy.
Kedhar SR; Jabs DA
Herpes; 2007 Dec; 14(3):66-71. PubMed ID: 18371289
[TBL] [Abstract][Full Text] [Related]
19. New drug applications sought.
AIDS Alert; 1995 Sep; 10(9):119-20. PubMed ID: 11362777
[TBL] [Abstract][Full Text] [Related]
20. Cytomegalovirus glycoprotein B genotypes and central nervous system disease in AIDS patients.
Vilas Boas LS; de Souza VA; Penalva de Oliveira AC; Rodriguez Viso AT; Nascimento Filho AM; Nascimento MC; Pannuti CS
J Med Virol; 2003 Nov; 71(3):404-7. PubMed ID: 12966546
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
